Shaping the future of diabetes care - Roche

More documents

Recommendations

Info

Valuation Share development of Disetronic CHF / Share Average: 10 days CHF 536, 1 month CHF 557, 3 months CHF 563, 1 year CHF 670 1600 1400 1200 1000 800 600 400 200 0 02 January 2002 02 April 2002 02 July 2002 02 October 2002 02 January 2003 Offer r 543 CHF 7.02.03 20
Transaction multiples based upon the tender offer 01/02 2004E EV/ Sales 4.9 3.3 EV/ EBIT 35 17 EV/ EBITDA 25 14 r 21
Page 1 and 2: Shaping the future of diabetes care
Page 3 and 4: The idea Roche Diagnostics, the wor
Page 5 and 6: Strategic rationale Shaping the fut
Page 7 and 8: Diabetes: a problem of epidemic pro
Page 9 and 10: Glucose monitoring and insulin deli
Page 11 and 12: Roche adding marketing and sales mu
Page 13 and 14: Entry into insulin pump market Grow
Page 15 and 16: Disetronic, the world’s No. 2 in
Page 17 and 18: Business model with two elements br
Page 19: Proposed transaction structure r Ef
Page 23 and 24: Public tender offer on Disetronic s
Page 25 and 26: About Roche Diabetes Care • Pione
Page 27 and 28: Diabetes is not curable, but it is

Shaping the future of diabetes care - Roche

Create successful ePaper yourself

Delete template?

Save as template?